Protara Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $21.2M | $36.4M | $40.0M | $68.8M | $2.8M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $43.5M | $42.8M | $66.6M | $84.6M | $5.3M |
| Property, Plant & Equipment | $259.0K | $372.0K | $224.0K | $83.0K | $62.0K |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $44.0M | $43.5M | $67.5M | $84.8M | $5.7M |
| Liabilities | |||||
| Accounts Payable | $291.0K | $556.0K | $1.0M | $917.0K | $399.0K |
| Total Current Liabilities | $9.2M | $5.1M | $4.1M | $2.3M | $9.8M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $9.2M | $5.1M | $4.1M | $2.3M | $9.8M |
| Stockholders' Equity | |||||
| Retained Earnings | $-189.7M | $-159.8M | $-131.3M | $-109.9M | $-100.5M |
| Total Stockholders' Equity | $34.7M | $38.4M | $63.4M | $82.5M | $-100.5M |